Michael Myers

Insider Reports History

Location
Tel Aviv, Israel
Signature
/s/ Michael Myers
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Myers:

Form 4 holding Chief Executive Officer, Director

Quoin Pharmaceuticals, Ltd.

Security class
Share Option (Right to Buy)
Shares / value
318,750
Estimated value
Report date
04 Feb 2026
Price
Ownership
Direct
Underlying class
ADS
Underlying amount

Insider Reports Filed by Michael Myers

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .